SMS Lifesciences India Dividend Record Date is Tomorrow, Sep 24

SMS Lifesciences India Limited (NSE: SMSLIFE) has confirmed the record date for its final dividend for the financial year 2024-25. The Board of Directors recommended a dividend of ₹1.50 per equity share, which is subject to shareholder approval at the company’s upcoming Annual General Meeting (AGM). The 19th AGM is scheduled to be held on Tuesday, September 30, 2025.

Record Date and Ex-Date Details

The company has fixed Wednesday, September 24, 2025, as the record date to determine the eligibility of shareholders entitled to receive the dividend and participate in the voting at the AGM. The corresponding ex-dividend date has been set as September 24, 2025. Shareholders holding shares as of the record date will be eligible for the payout once approved.

Dividend Payment Timeline

Once shareholders approve the dividend during the AGM, the company will initiate the payout process. As per regulatory guidelines, the dividend will be paid within 30 days of the AGM approval. The payment will be made directly to the shareholders’ registered bank accounts, after deduction of applicable tax at source (TDS).

Historical Context

In the previous financial year 2023-24, SMS Lifesciences India had also declared a dividend of ₹1.50 per share. The record date then was September 24, 2024, with the book closure period from September 24 to September 30, 2024. This reflects consistency in the company’s approach toward shareholder returns.

Also Read: Dividends, Stock Splits & Bonus Issues This Week (Sep 22 – 26)!

Conclusion

With the record date set for September 24, 2025, eligible investors can look forward to distribution following shareholder approval at the AGM. Shareholders must hold shares in a valid demat account as of the record date to be eligible for the dividend.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.